The global Codeine Phosphate API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Codeine Phosphate API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Codeine Phosphate API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Codeine Phosphate API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Codeine Phosphate API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Codeine Phosphate API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Codeine Phosphate API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Codeine Phosphate API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Noramco, Johnson Matthey, Siegfried USA, SpecGx, Salars SpA, Sun Pharmaceutical Industries, Alcaliber SA, Fine Chemicals Corporation, Chr. Olesen Synthesis, Saneca Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Codeine Phosphate API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Purity Above 97%
Purity Below 97%
麻豆原创 segment by Application
Tablet
Injection
Syrup
Major players covered
Noramco
Johnson Matthey
Siegfried USA
SpecGx
Salars SpA
Sun Pharmaceutical Industries
Alcaliber SA
Fine Chemicals Corporation
Chr. Olesen Synthesis
Saneca Pharmaceuticals
Palla Pharma
Francopia
TPI
China National Pharmaceutical Industry
Qinghai Pharmaceutical Factory
Yichang Humanwell Pharmaceutical
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Codeine Phosphate API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Codeine Phosphate API, with price, sales quantity, revenue, and global market share of Codeine Phosphate API from 2020 to 2025.
Chapter 3, the Codeine Phosphate API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Codeine Phosphate API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Codeine Phosphate API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Codeine Phosphate API.
Chapter 14 and 15, to describe Codeine Phosphate API sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Codeine Phosphate API Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Purity Above 97%
1.3.3 Purity Below 97%
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Codeine Phosphate API Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Tablet
1.4.3 Injection
1.4.4 Syrup
1.5 Global Codeine Phosphate API 麻豆原创 Size & Forecast
1.5.1 Global Codeine Phosphate API Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Codeine Phosphate API Sales Quantity (2020-2031)
1.5.3 Global Codeine Phosphate API Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Noramco
2.1.1 Noramco Details
2.1.2 Noramco Major Business
2.1.3 Noramco Codeine Phosphate API Product and Services
2.1.4 Noramco Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Noramco Recent Developments/Updates
2.2 Johnson Matthey
2.2.1 Johnson Matthey Details
2.2.2 Johnson Matthey Major Business
2.2.3 Johnson Matthey Codeine Phosphate API Product and Services
2.2.4 Johnson Matthey Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Johnson Matthey Recent Developments/Updates
2.3 Siegfried USA
2.3.1 Siegfried USA Details
2.3.2 Siegfried USA Major Business
2.3.3 Siegfried USA Codeine Phosphate API Product and Services
2.3.4 Siegfried USA Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Siegfried USA Recent Developments/Updates
2.4 SpecGx
2.4.1 SpecGx Details
2.4.2 SpecGx Major Business
2.4.3 SpecGx Codeine Phosphate API Product and Services
2.4.4 SpecGx Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 SpecGx Recent Developments/Updates
2.5 Salars SpA
2.5.1 Salars SpA Details
2.5.2 Salars SpA Major Business
2.5.3 Salars SpA Codeine Phosphate API Product and Services
2.5.4 Salars SpA Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Salars SpA Recent Developments/Updates
2.6 Sun Pharmaceutical Industries
2.6.1 Sun Pharmaceutical Industries Details
2.6.2 Sun Pharmaceutical Industries Major Business
2.6.3 Sun Pharmaceutical Industries Codeine Phosphate API Product and Services
2.6.4 Sun Pharmaceutical Industries Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Sun Pharmaceutical Industries Recent Developments/Updates
2.7 Alcaliber SA
2.7.1 Alcaliber SA Details
2.7.2 Alcaliber SA Major Business
2.7.3 Alcaliber SA Codeine Phosphate API Product and Services
2.7.4 Alcaliber SA Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Alcaliber SA Recent Developments/Updates
2.8 Fine Chemicals Corporation
2.8.1 Fine Chemicals Corporation Details
2.8.2 Fine Chemicals Corporation Major Business
2.8.3 Fine Chemicals Corporation Codeine Phosphate API Product and Services
2.8.4 Fine Chemicals Corporation Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Fine Chemicals Corporation Recent Developments/Updates
2.9 Chr. Olesen Synthesis
2.9.1 Chr. Olesen Synthesis Details
2.9.2 Chr. Olesen Synthesis Major Business
2.9.3 Chr. Olesen Synthesis Codeine Phosphate API Product and Services
2.9.4 Chr. Olesen Synthesis Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Chr. Olesen Synthesis Recent Developments/Updates
2.10 Saneca Pharmaceuticals
2.10.1 Saneca Pharmaceuticals Details
2.10.2 Saneca Pharmaceuticals Major Business
2.10.3 Saneca Pharmaceuticals Codeine Phosphate API Product and Services
2.10.4 Saneca Pharmaceuticals Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Saneca Pharmaceuticals Recent Developments/Updates
2.11 Palla Pharma
2.11.1 Palla Pharma Details
2.11.2 Palla Pharma Major Business
2.11.3 Palla Pharma Codeine Phosphate API Product and Services
2.11.4 Palla Pharma Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Palla Pharma Recent Developments/Updates
2.12 Francopia
2.12.1 Francopia Details
2.12.2 Francopia Major Business
2.12.3 Francopia Codeine Phosphate API Product and Services
2.12.4 Francopia Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Francopia Recent Developments/Updates
2.13 TPI
2.13.1 TPI Details
2.13.2 TPI Major Business
2.13.3 TPI Codeine Phosphate API Product and Services
2.13.4 TPI Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 TPI Recent Developments/Updates
2.14 China National Pharmaceutical Industry
2.14.1 China National Pharmaceutical Industry Details
2.14.2 China National Pharmaceutical Industry Major Business
2.14.3 China National Pharmaceutical Industry Codeine Phosphate API Product and Services
2.14.4 China National Pharmaceutical Industry Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 China National Pharmaceutical Industry Recent Developments/Updates
2.15 Qinghai Pharmaceutical Factory
2.15.1 Qinghai Pharmaceutical Factory Details
2.15.2 Qinghai Pharmaceutical Factory Major Business
2.15.3 Qinghai Pharmaceutical Factory Codeine Phosphate API Product and Services
2.15.4 Qinghai Pharmaceutical Factory Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Qinghai Pharmaceutical Factory Recent Developments/Updates
2.16 Yichang Humanwell Pharmaceutical
2.16.1 Yichang Humanwell Pharmaceutical Details
2.16.2 Yichang Humanwell Pharmaceutical Major Business
2.16.3 Yichang Humanwell Pharmaceutical Codeine Phosphate API Product and Services
2.16.4 Yichang Humanwell Pharmaceutical Codeine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Codeine Phosphate API by Manufacturer
3.1 Global Codeine Phosphate API Sales Quantity by Manufacturer (2020-2025)
3.2 Global Codeine Phosphate API Revenue by Manufacturer (2020-2025)
3.3 Global Codeine Phosphate API Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Codeine Phosphate API by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Codeine Phosphate API Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Codeine Phosphate API Manufacturer 麻豆原创 Share in 2024
3.5 Codeine Phosphate API 麻豆原创: Overall Company Footprint Analysis
3.5.1 Codeine Phosphate API 麻豆原创: Region Footprint
3.5.2 Codeine Phosphate API 麻豆原创: Company Product Type Footprint
3.5.3 Codeine Phosphate API 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Codeine Phosphate API 麻豆原创 Size by Region
4.1.1 Global Codeine Phosphate API Sales Quantity by Region (2020-2031)
4.1.2 Global Codeine Phosphate API Consumption Value by Region (2020-2031)
4.1.3 Global Codeine Phosphate API Average Price by Region (2020-2031)
4.2 North America Codeine Phosphate API Consumption Value (2020-2031)
4.3 Europe Codeine Phosphate API Consumption Value (2020-2031)
4.4 Asia-Pacific Codeine Phosphate API Consumption Value (2020-2031)
4.5 South America Codeine Phosphate API Consumption Value (2020-2031)
4.6 Middle East & Africa Codeine Phosphate API Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Codeine Phosphate API Sales Quantity by Type (2020-2031)
5.2 Global Codeine Phosphate API Consumption Value by Type (2020-2031)
5.3 Global Codeine Phosphate API Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Codeine Phosphate API Sales Quantity by Application (2020-2031)
6.2 Global Codeine Phosphate API Consumption Value by Application (2020-2031)
6.3 Global Codeine Phosphate API Average Price by Application (2020-2031)
7 North America
7.1 North America Codeine Phosphate API Sales Quantity by Type (2020-2031)
7.2 North America Codeine Phosphate API Sales Quantity by Application (2020-2031)
7.3 North America Codeine Phosphate API 麻豆原创 Size by Country
7.3.1 North America Codeine Phosphate API Sales Quantity by Country (2020-2031)
7.3.2 North America Codeine Phosphate API Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Codeine Phosphate API Sales Quantity by Type (2020-2031)
8.2 Europe Codeine Phosphate API Sales Quantity by Application (2020-2031)
8.3 Europe Codeine Phosphate API 麻豆原创 Size by Country
8.3.1 Europe Codeine Phosphate API Sales Quantity by Country (2020-2031)
8.3.2 Europe Codeine Phosphate API Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Codeine Phosphate API Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Codeine Phosphate API Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Codeine Phosphate API 麻豆原创 Size by Region
9.3.1 Asia-Pacific Codeine Phosphate API Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Codeine Phosphate API Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Codeine Phosphate API Sales Quantity by Type (2020-2031)
10.2 South America Codeine Phosphate API Sales Quantity by Application (2020-2031)
10.3 South America Codeine Phosphate API 麻豆原创 Size by Country
10.3.1 South America Codeine Phosphate API Sales Quantity by Country (2020-2031)
10.3.2 South America Codeine Phosphate API Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Codeine Phosphate API Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Codeine Phosphate API Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Codeine Phosphate API 麻豆原创 Size by Country
11.3.1 Middle East & Africa Codeine Phosphate API Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Codeine Phosphate API Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Codeine Phosphate API 麻豆原创 Drivers
12.2 Codeine Phosphate API 麻豆原创 Restraints
12.3 Codeine Phosphate API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Codeine Phosphate API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Codeine Phosphate API
13.3 Codeine Phosphate API Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Codeine Phosphate API Typical Distributors
14.3 Codeine Phosphate API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Noramco
Johnson Matthey
Siegfried USA
SpecGx
Salars SpA
Sun Pharmaceutical Industries
Alcaliber SA
Fine Chemicals Corporation
Chr. Olesen Synthesis
Saneca Pharmaceuticals
Palla Pharma
Francopia
TPI
China National Pharmaceutical Industry
Qinghai Pharmaceutical Factory
Yichang Humanwell Pharmaceutical
听
听
*If Applicable.
